Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Fatigue 6Brain Neoplasms 3Sleep Wake Disorders 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Pain 1Mental Disorders 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Depression 1Central Nervous System Neoplasms 1Caregiver Burden 1Breast Neoplasms 1

Interventions

Methylphenidate 2Melatonin 2Educational Status 2Early Intervention, Educational 2Counseling 2exemestane 1Yoga 1Ultraviolet Therapy 1Triptorelin Pamoate 1Therapeutics 1Tamoxifen 1Phototherapy 1Modafinil 1Methods 1Gonadotropin-Releasing Hormone 1Exercise Test 1Donepezil 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Sleep Wake Disorders × Methylphenidate × Clear all
NCT01628029 2026-05-22

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
68 enrolled 16 charts
Other hematologic neoplasm

Sleep Wake Disorders, Hematologic Neoplasms

NCT01348607 2014-02-21

Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy

University of South Florida

Phase 2 Terminated
1 enrolled 5 charts
CNS

Fatigue, Sleep Wake Disorders, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡